— Know what they know.
Not Investment Advice

VCEL NASDAQ

Vericel Corporation
1W: +6.1% 1M: +2.3% 3M: -7.7% YTD: -1.3% 1Y: -19.2% 3Y: +6.3% 5Y: -30.8%
$34.73
-0.42 (-1.19%)
 
Weekly Expected Move ±7.1%
$28 $31 $33 $35 $38
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 58 · $1.8B mcap · 50M float · 1.32% daily turnover · Short 59% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$276M +16.5% ▲
5Y CAGR: +17.3%
Gross Profit
$206M +19.5% ▲
5Y CAGR: +19.5%
Operating Income
$11M +144.4% ▲
5Y CAGR: +36.0%
Net Income
$17M +59.4% ▲
5Y CAGR: +42.0%
EPS (Diluted)
$0.32 +60.0% ▲
5Y CAGR: +39.5%
EBITDA
$30M +82.2% ▲
5Y CAGR: +41.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$156M$164M$198M$237M$276M
YoY Growth+25.8%+5.2%+20.2%+20.1%+16.5%
Cost of Revenue$50M$55M$62M$65M$71M
Gross Profit$106M$110M$136M$172M$206M
Gross Margin67.9%66.8%68.6%72.6%74.4%
R&D Expenses$16M$20M$21M$25M$28M
SG&A Expenses$98M$107M$121M$143M$167M
Operating Expenses$114M$127M$142M$168M$195M
Operating Income-$8M-$17M-$6M$5M$11M
Operating Margin-5.0%-10.4%-3.3%1.9%4.0%
Interest Expense$4K$366K$600K$614K$2M
Income Before Tax-$8M-$16M-$2M$11M$17M
Tax Expense-$111K$721K$814K$148K$859K
Net Income-$7M-$17M-$3M$10M$17M
Net Margin-4.8%-10.2%-1.6%4.4%6.0%
EPS (Diluted)$-0.16$-0.35$-0.07$0.20$0.32
EBITDA-$5M-$12M$3M$17M$30M
Shares Outstanding46M47M48M52M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms